MedTrace Logo

Lyophilized Fecal Microbiota Transplantation for Recurrent Clostridioides Difficile Infection

NCT03834038 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 158

Last updated 2024-09-23

Study results available
· View outcomes & findings →

Summary

The primary goal is to study participants with recurrent C. difficile infection (CDI) treated with lyophilized fecal microbiota transplantation (FMT). The safety, clinical response and relapse rate in patients will be assessed.

Conditions

  • Recurrent Clostridium Difficile Infection

Interventions

DRUG

Lyophilized Fecal Microbiota Transplantation

Lyophilized FMT

Sponsors & Collaborators

  • Vancouver Island Health Authority

    lead OTHER

Principal Investigators

  • Christine Lee, MD · Vancouver Island Health Authority

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-01
Primary Completion
2018-03-01
Completion
2020-03-17

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03834038 on ClinicalTrials.gov